Document Detail

Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: A systematic review and meta-analysis of randomized controlled trials.
MedLine Citation:
PMID:  24530783     Owner:  NLM     Status:  Publisher    
OBJECTIVE: This study was undertaken to evaluate the efficacy of intramyocardial bone marrow cell (BMC) transplant therapy for ischemic heart disease (IHD).
METHODS: The PubMed, Embase, and Cochrane Library databases through October 2013 were searched for randomized clinical trials (RCTs) of intramyocardial BMCs to treat IHD. The primary endpoint was change in left ventricular ejection fraction (LVEF). Secondary endpoints were changes in left ventricular end-systolic volume (LVESV) and left ventricular end-diastolic volume (LVEDV). Weighted mean differences for the changes were estimated with a random-effects model.
RESULTS: Eleven RCTs with 492 participants were included. Intramyocardial BMC transplantation increased LVEF (4.91%; 95% confidence interval [CI] 2.84%-6.99%; P < 0.00001), reduced LVESV (10.66 mL; 95% CI, -18.92 mL to -2.41 mL; P = 0.01), and showed a trend toward decreased LVEDV (-7.82 mL; 95% CI, -16.36 mL-0.71 mL; P = 0.07). Patients suitable for revascularization with coronary artery bypass grafting had greater improvement in LVEF (7.60%; 95% CI, 4.74%-10.46%, P < 0.00001) than those unsuitable for revascularization (3.76%; 95% CI, 2.20%-5.32%; P < 0.00001). LVEDV reduction was also more significant in revascularizable IHD (-16.51 mL; 95% CI, -22.05 mL to -10.07 mL; P < 0.00001) than non-revascularizable IHD (-0.89 mL; 95% CI, -8.44 mL-6.66 mL; P = 0.82).
CONCLUSION: Intramyocardial BMC injection contributes to improvement in left ventricular dysfunction and reduction in left ventricular volume. Patients with revascularizable IHD may benefit more from this therapy.
Tao Tian; Bingwei Chen; Yan Xiao; Kunqi Yang; Xianliang Zhou
Related Documents :
938173 - Acute myocardial infarction in an american traveler in china.
2591393 - Symptoms and signs of heart failure in patients with myocardial infarction: reproducibi...
3147243 - Myocardial infarction, persistent coronary artery thrombosis and lupus anticoagulant.
Publication Detail:
Type:  REVIEW     Date:  2014-1-23
Journal Detail:
Title:  Atherosclerosis     Volume:  233     ISSN:  1879-1484     ISO Abbreviation:  Atherosclerosis     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-2-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  485-492     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Retinal microvascular structure and function in patients with risk factors of atherosclerosis and co...
Next Document:  Mono-allelic and bi-allelic ENPP1 deficiency promote post-injury neointimal hyperplasia associated w...